Halozyme Therapeutics | HALO - نسبة السعر إلى الأرباح





Pe تغيير تاريخ
Acadia Pharmaceuticals 10.08 1.53 2026-03
Agios Pharmaceuticals 3.56 0 2026-03
Alnylam Pharmaceuticals 80.04 90.66 2026-03
Amarin 91.05 88.3 2023-06
Amgen 19.84 5.47 2026-03
Baxter International 86 68.9 2025-12
Cara Therapeutics 27.77 117.09 2021-09
Eli Lilly 40.27 0.06 2026-03
Esperion Therapeutics 129.79 129 2024-12
Halozyme Therapeutics 11.35 11.8 2026-03
Intrexon 7.54 221.44 2021-12
Ionis Pharmaceuticals 396.15 79.28 2022-09
MannKind 201.15 102.55 2026-03
Pfizer 9.32 5.16 2026-03
Rigel Pharmaceuticals 8.61 8.4 2025-03
United Therapeutics 20.42 3.1 2026-03
Vanda Pharmaceuticals 16.79 7.07 2023-06